Family · Pharmaceutical analytical standards
Rupatadine
A second-generation, non-sedating, long-acting antihistamine developed in Spain and on the market since 2003: it is approved for allergic rhinitis and chronic urticaria. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Besides histamine it also blocks PAF, platelet-activating factor, another mediator of allergy. In the body it is partly converted into desloratadine, itself an antihistamine.
No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
